You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gaucher's disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bone in Pediatric Gaucher Disease Related to Bone Pathology in

Recruiting
  • Gaucher Disease
  • Bone Diseases
    • Fairfax, Virginia
      Lysosomal and Rare disorder research and treatment center
    Nov 6, 2023

    Gaucher Disease Type 1 Trial in Jerusalem (Enzyme replacement therapy for Gaucher disease in combination with altus care

    Completed
    • Gaucher Disease Type 1
    • Enzyme replacement therapy for Gaucher disease in combination with altus care application
    • Jerusalem, Israel
      Hebrew university
    Sep 18, 2023

    Neurological Manifestations in Gaucher Disease Patients

    Not yet recruiting
    • Gaucher Disease
      • (no location specified)
      Apr 14, 2023

      Therapeutic Target in Gaucher Disease

      Not yet recruiting
      • Gaucher Disease
      • no intervention
      • Minneapolis, Minnesota
        University of Minnesota
      Apr 24, 2023

      Gaucher Disease Trial (Investigational procedure)

      Not yet recruiting
      • Gaucher Disease
      • Investigational procedure
      • (no location specified)
      Jun 8, 2023

      Substances Potentially Indicating Bone Problems in Type 1

      Not yet recruiting
      • Gaucher Disease
      • No Intervention
      • Zaragoza, Aragon, Spain
        Fundación Española para el Estudio y Tratamiento de la Enfermeda
      Jan 18, 2023

      Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)

      Not yet recruiting
      • Gaucher Disease, Type 3
      • Gene therapy
      • Enzyme Replacement Agent
      • (no location specified)
      Apr 14, 2023

      Velaglucerase Alfa Given as Standard Patient Care in Young

      Recruiting
      • Gaucher Disease
      • Standard of Care
      • Fairfax, Virginia
        Lysosomal & Rare Disorders Research & Treatment Center
      Jan 5, 2023

      MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER

      Not yet recruiting
      • Gaucher Disease, Type 3
      • No intervention
      • Minneapolis, Minnesota
        University of Minnesota
      Oct 16, 2022

      Positron Emission Tomography Imaging in People With Gaucher

      Completed
      • Parkinson Disease
      • Gaucher Disease
      • 15-0 H20
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 18, 2023

      Gaucher Disease, Type III Trial in Taipei (Eliglustat)

      Completed
      • Gaucher Disease, Type III
      • Taipei, Taiwan
        National Taiwan University Hospital
      Sep 13, 2022

      Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in

      Recruiting
      • Gaucher Disease
      • Acid SphingoMyelinase Deficiency
        • Ponferrada, León, Spain
        • +11 more
        Aug 8, 2023

        Gaucher Disease, Type 1, Gaucher Disease, Type 3 Trial in Beijing (Low-dose CAN103, High-dose CAN103)

        Recruiting
        • Gaucher Disease, Type 1
        • Gaucher Disease, Type 3
        • Low-dose CAN103
        • High-dose CAN103
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jul 25, 2022

        Genetic Studies of Lysosomal Storage Disorders

        Enrolling by invitation
        • Lysosomal Storage Disorders
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 21, 2023

          PREDIGA 2: Spanish Acronym of "Educational and Diagnostic

          Not yet recruiting
          • Gaucher Disease
          • +4 more
          • Patient with splenomegaly or splenectomy
          • Barcelona, Spain
            Hospital Vall d'Hebron
          Dec 13, 2022

          Digital Health Platform Customized for Gaucher Disease

          Recruiting
          • Gaucher Disease
          • Patient Reported Outcome
          • Digital Gaucher Platform
          • Jerusalem, Israel
            Shaare Zedek Medical Center
          May 24, 2022

          Gaucher Disease, Type 1 Trial (quantitative chemical shift imaging (QCSI), Elelyso)

          Completed
          • Gaucher Disease, Type 1
          • quantitative chemical shift imaging (QCSI)
          • Elelyso
          • (no location specified)
          Oct 27, 2022

          Gaucher Disease Trial in Australia, Canada, United States (AVR-RD-02)

          Recruiting
          • Gaucher Disease
          • Iowa City, Iowa
          • +2 more
          Oct 20, 2022

          Gaucher's Disease Type I Trial (Genz-112638, [14C]-Genz-112638)

          Completed
          • Gaucher's Disease Type I
          • (no location specified)
          Nov 16, 2023

          Gaucher Disease, Type 1 Trial in Jerusalem (Ambroxol)

          Active, not recruiting
          • Gaucher Disease, Type 1
          • Jerusalem, Israel
            Shaare Zedek Medical Center
          May 24, 2022

          Assess Participants', Caregivers', and Nurses' Use and

          Not yet recruiting
          • Gaucher Disease
            • (no location specified)
            Dec 20, 2022

            Gaucher Disease, Type 1 Trial in Worldwide (FLT201)

            Recruiting
            • Gaucher Disease, Type 1
            • FLT201
            • Córdoba, Argentina
            • +15 more
            Jan 26, 2023

            Gaucher Disease Trial in Durham, Fairfax (LY3884961, Methylprednisolone, Sirolimus)

            Not yet recruiting
            • Gaucher Disease
            • LY3884961
            • +3 more
            • Durham, North Carolina
            • +1 more
            Aug 1, 2022

            Gaucher's Disease Trial in Beijing, Chengdu, Guangzhou (Cerezyme® / Imiglucerase)

            Recruiting
            • Gaucher's Disease
            • Cerezyme® / Imiglucerase
            • Beijing, China
            • +4 more
            Jul 12, 2022

            Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)

            Active, not recruiting
            • Gaucher Disease Type 1
            • Gaucher Disease Type 3
            • New Haven, Connecticut
            • +6 more
            Aug 9, 2022